Koers MusclePharm Corporation Other OTC
Aandelen
MSLP
US6273352012
Holdingvennootschappen
Omzet 2020 | 64,44 mln. 60,37 mln. | Omzet 2021 | 50,04 mln. 46,88 mln. | Marktkapitalisatie | 13,35 mln. 12,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | 3 mln. 2,81 mln. | Nettowinst (verlies) 2021 | -12 mln. -11,24 mln. | EV/omzet 2020 | 0,27 x |
Nettoschuld 2020 | 10,43 mln. 9,77 mln. | Nettoschuld 2021 | 15,93 mln. 14,92 mln. | EV/omzet 2021 | 0,59 x |
K/w-verhouding 2020 |
2,55
x | K/w-verhouding 2021 |
-1,03
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 88,94% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eric Hillman
CEO | Chief Executive Officer | - | 13-02-23 |
Eric Chin
DFI | Director of Finance/CFO | 44 | 17-06-22 |
Chairman | 53 | 26-08-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eric Hillman
CEO | Chief Executive Officer | - | 13-02-23 |
Michael Heller
BRD | Director/Board Member | 48 | 19-01-21 |
Chairman | 53 | 26-08-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+161,31% | 6,83 mld. | |
+0,47% | 1,01 mld. | |
+2,29% | 982 mln. | |
+41,91% | 872 mln. | |
+22,53% | 797 mln. | |
+1,82% | 664 mln. | |
-1,80% | 617 mln. | |
-.--% | 600 mln. | |
+27,27% | 592 mln. |